Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment

Lignende værker

• Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice
  af: Taylor, Peter C, et al.
  Udgivet: (2018)
• A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective
  af: Taylor, Peter C., et al.
  Udgivet: (2016)
• Subcutaneous Abatacept vErsus Intravenous Abatacept: A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to Methotrexate
  af: Genovese, M C, et al.
  Udgivet: (2011)
• Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studies
  af: Genovese, Mark C, et al.
  Udgivet: (2020)
• Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors
  af: Strand, Vibeke, et al.
  Udgivet: (2017)